Amos de Jong

Researcher/Postdoc

Biography

Amos de Jong obtained his PhD in Drug Innovation from the Utrecht University in 2024. Amos’ PhD thesis focuses on the regulatory aspects of decentralized clinical trials and encompasses both qualitative and quantitative research methods. He works as a Postdoc at the Julius Center (Epidemiology of Infectious Diseases) of the University Medical Center Utrecht. In this Postdoc position, his research will focus on the regulatory aspects of (operational and methodological) clinical trial innovation, focusing on adaptive platform trials.

Contact

ajong45@umcutrecht.nl

Pure profile

Recent publications

All publications

Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines Christine C van Hattem, Amos J de Jong, Jolien S de Groot, Jarno Hoekman, K Esther Broekman, Gabe S Sonke, Paula B van Hennik, Lourens T Bloem
BMJ Open, 2024, vol. 14

Regulatory readiness to facilitate the appropriate use of innovation in clinical trials Amos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, Anthonius de Boer, Helga Gardarsdottir,
Drug Discovery Today, 2024, vol. 29

Opportunities and Challenges for Decentralized Clinical Trial Approaches Amos J. de Jong, Nadi Shahid, Mira G.P. Zuidgeest, Yared Santa-Ana-Tellez, Milou Hogervorst, Wim Goettsch, Hamidou Traore, Anthonius de Boer, Helga Gardarsdottir,
Value in Health, 2023, vol. 27, p.294-300

Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus Yared Santa-Ana-Tellez, Bart Lagerwaard, Amos J. de Jong, Helga Gardarsdottir, Diederick E. Grobbee, Kimberly Hawkins, Megan Heath, Mira G.P. Zuidgeest,
Drug Discovery Today, 2023, vol. 28

Direct-to-participant investigational medicinal product supply in clinical trials in Europe Amos J. de Jong, Yared Santa-Ana-Tellez, Mira G.P. Zuidgeest, Renske J. Grupstra, Fatemeh Jami, Anthonius de Boer, Helga Gardarsdottir,
British Journal of Clinical Pharmacology, 2023, vol. 89, p.3512-3522

Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov Amos J. de Jong, Renske J. Grupstra, Yared Santa-Ana-Tellez, Mira G.P. Zuidgeest, Anthonius de Boer, Helga Gardarsdottir,
BMJ Open, 2022, vol. 12